Rote William E.'s Form 4 filing
Travere Therapeutics, Inc. (TVTX) · filed Jan 12, 2022
- Accession no.
- 0001209191-22-003050
- Filed
- Jan 12, 2022
- Trade date
- Jan 10-11, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $68.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rote William E.CIK 0001698262 | Officer (Senior Vice President, R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 10, 2022 | Common Stock | AGrant or awardAcquired | +5,000 | $0.00 | $0 | 40,895 | Direct | |
| Jan 11, 2022 | Common Stock | SSaleDisposed | −2,500 | $27.40 | −$68,500 | 38,395 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.